JP7183194B2 - 胃内容排出パラメータを測定するための嚥下可能カプセル、システム、および方法 - Google Patents
胃内容排出パラメータを測定するための嚥下可能カプセル、システム、および方法 Download PDFInfo
- Publication number
- JP7183194B2 JP7183194B2 JP2019568333A JP2019568333A JP7183194B2 JP 7183194 B2 JP7183194 B2 JP 7183194B2 JP 2019568333 A JP2019568333 A JP 2019568333A JP 2019568333 A JP2019568333 A JP 2019568333A JP 7183194 B2 JP7183194 B2 JP 7183194B2
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- signal
- electrodes
- controller
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims description 288
- 230000030136 gastric emptying Effects 0.000 title claims description 186
- 238000000034 method Methods 0.000 title claims description 66
- 210000002784 stomach Anatomy 0.000 claims description 101
- 210000000813 small intestine Anatomy 0.000 claims description 92
- 238000000576 coating method Methods 0.000 claims description 75
- 239000011248 coating agent Substances 0.000 claims description 68
- 239000012530 fluid Substances 0.000 claims description 31
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 29
- 238000005259 measurement Methods 0.000 claims description 22
- 239000002702 enteric coating Substances 0.000 claims description 21
- 238000009505 enteric coating Methods 0.000 claims description 21
- 230000004044 response Effects 0.000 claims description 17
- 230000002496 gastric effect Effects 0.000 claims description 14
- 230000007423 decrease Effects 0.000 claims description 8
- 230000000593 degrading effect Effects 0.000 claims description 6
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- 229910001416 lithium ion Inorganic materials 0.000 claims description 4
- 230000035440 response to pH Effects 0.000 claims description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 description 70
- 238000012360 testing method Methods 0.000 description 47
- 235000013305 food Nutrition 0.000 description 45
- 206010021518 Impaired gastric emptying Diseases 0.000 description 28
- 208000001288 gastroparesis Diseases 0.000 description 27
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 24
- 230000002572 peristaltic effect Effects 0.000 description 18
- 238000013459 approach Methods 0.000 description 16
- 238000004364 calculation method Methods 0.000 description 16
- 230000008602 contraction Effects 0.000 description 14
- 102000004877 Insulin Human genes 0.000 description 12
- 108090001061 Insulin Proteins 0.000 description 12
- 238000001514 detection method Methods 0.000 description 12
- 229940125396 insulin Drugs 0.000 description 12
- 235000021049 nutrient content Nutrition 0.000 description 12
- 239000003925 fat Substances 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 235000005686 eating Nutrition 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000002429 large intestine Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 8
- 238000004891 communication Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000001198 duodenum Anatomy 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 229920003134 Eudragit® polymer Polymers 0.000 description 6
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 239000000859 incretin Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 5
- 108010011459 Exenatide Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 206010028813 Nausea Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002594 fluoroscopy Methods 0.000 description 4
- 210000003736 gastrointestinal content Anatomy 0.000 description 4
- 210000001630 jejunum Anatomy 0.000 description 4
- 230000008693 nausea Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960001519 exenatide Drugs 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 108091006146 Channels Proteins 0.000 description 2
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 description 2
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 2
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 229940084891 byetta Drugs 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 235000013410 fast food Nutrition 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000021134 protein-rich food Nutrition 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000021055 solid food Nutrition 0.000 description 2
- 238000011410 subtraction method Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 235000021195 test diet Nutrition 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 229910001020 Au alloy Inorganic materials 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010059186 Early satiety Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 230000002039 glucoregulatory effect Effects 0.000 description 1
- 239000003353 gold alloy Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6861—Capsules, e.g. for swallowing or implanting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
- A61B5/036—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs by means introduced into body tracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/073—Intestinal transmitters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4238—Evaluating particular parts, e.g. particular organs stomach
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4255—Intestines, colon or appendix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0247—Pressure sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/162—Capsule shaped sensor housings, e.g. for swallowing or implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0026—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the transmission medium
- A61B5/0028—Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7225—Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022186247A JP2023010877A (ja) | 2017-06-12 | 2022-11-22 | 患者の消化管内における胃内容排出パラメータを測定するための嚥下可能カプセルおよびシステム |
| JP2024101550A JP2024116415A (ja) | 2017-06-12 | 2024-06-24 | 患者の消化管内における胃内容排出パラメータを測定するための嚥下可能カプセルおよびシステム |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762518246P | 2017-06-12 | 2017-06-12 | |
| US62/518,246 | 2017-06-12 | ||
| PCT/US2018/037153 WO2018231865A2 (en) | 2017-06-12 | 2018-06-12 | Swallowable capsule, system and method for measuring gastric emptying parameters |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022186247A Division JP2023010877A (ja) | 2017-06-12 | 2022-11-22 | 患者の消化管内における胃内容排出パラメータを測定するための嚥下可能カプセルおよびシステム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020523123A JP2020523123A (ja) | 2020-08-06 |
| JP2020523123A5 JP2020523123A5 (enExample) | 2021-07-26 |
| JP7183194B2 true JP7183194B2 (ja) | 2022-12-05 |
Family
ID=64562740
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019568333A Active JP7183194B2 (ja) | 2017-06-12 | 2018-06-12 | 胃内容排出パラメータを測定するための嚥下可能カプセル、システム、および方法 |
| JP2022186247A Pending JP2023010877A (ja) | 2017-06-12 | 2022-11-22 | 患者の消化管内における胃内容排出パラメータを測定するための嚥下可能カプセルおよびシステム |
| JP2024101550A Withdrawn JP2024116415A (ja) | 2017-06-12 | 2024-06-24 | 患者の消化管内における胃内容排出パラメータを測定するための嚥下可能カプセルおよびシステム |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022186247A Pending JP2023010877A (ja) | 2017-06-12 | 2022-11-22 | 患者の消化管内における胃内容排出パラメータを測定するための嚥下可能カプセルおよびシステム |
| JP2024101550A Withdrawn JP2024116415A (ja) | 2017-06-12 | 2024-06-24 | 患者の消化管内における胃内容排出パラメータを測定するための嚥下可能カプセルおよびシステム |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11103187B2 (enExample) |
| EP (1) | EP3638111A4 (enExample) |
| JP (3) | JP7183194B2 (enExample) |
| CN (2) | CN115844361A (enExample) |
| AU (1) | AU2018282907B2 (enExample) |
| CA (1) | CA3067021A1 (enExample) |
| WO (1) | WO2018231865A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8759284B2 (en) | 2009-12-24 | 2014-06-24 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10689460B2 (en) | 2014-05-15 | 2020-06-23 | Incube Labs, Llc | PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| CN109464742B (zh) * | 2018-12-29 | 2024-08-09 | 上海安翰医疗技术有限公司 | 胃肠道定位开关及其制作方法及消化道定点药物释放胶囊 |
| CN119719690B (zh) * | 2025-02-27 | 2025-06-20 | 北京亿家老小科技有限公司 | 一种多维度监控的饱腹感与占胃胶囊效果评估优化方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006517827A (ja) | 2003-01-29 | 2006-08-03 | イー−ピル・ファーマ・リミテッド | 胃腸管内における活性薬物の送達 |
| US20080065168A1 (en) | 2005-12-05 | 2008-03-13 | Ophir Bitton | Ingestible Capsule For Appetite Regulation |
| US20090318783A1 (en) | 2008-06-18 | 2009-12-24 | Rohde Bemina L | System and method of evaluating a subject with an ingestible capsule |
| CN102088281A (zh) | 2009-12-04 | 2011-06-08 | 北京华清益康科技有限责任公司 | 一种基于消化道内体液酸碱度的电开关装置 |
| WO2011092936A1 (ja) | 2010-01-27 | 2011-08-04 | オリンパス株式会社 | 電源システム及び、その電源システムを搭載する医療用カプセル装置 |
| JP2012511961A (ja) | 2008-12-11 | 2012-05-31 | プロテウス バイオメディカル インコーポレイテッド | 携帯用内臓電気記録システムを用いた消化管機能の判断およびそれを用いた方法 |
| JP2015142754A (ja) | 2008-08-13 | 2015-08-06 | プロテウス デジタル ヘルス, インコーポレイテッド | 摂取可能デバイスおよびそれを生成する方法 |
| US20170000180A1 (en) | 2011-07-11 | 2017-01-05 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3739279A (en) * | 1971-06-30 | 1973-06-12 | Corning Glass Works | Radio capsule oscillator circuit |
| US5187154A (en) * | 1990-12-13 | 1993-02-16 | Board Of Regents, The University Of Texas System | Diagnosis and treatment of humans with diabetes or at risk to develop diabetes |
| US7160258B2 (en) | 2001-06-26 | 2007-01-09 | Entrack, Inc. | Capsule and method for treating or diagnosing the intestinal tract |
| EP1578260B1 (en) * | 2002-12-16 | 2012-10-24 | Given Imaging Ltd. | Device, system and method for selective activation of in vivo sensors |
| KR100873683B1 (ko) * | 2003-01-25 | 2008-12-12 | 한국과학기술연구원 | 인체통신방법, 인체통신시스템 및 이에 사용되는 캡슐형 내시경 |
| US7918786B2 (en) * | 2003-11-11 | 2011-04-05 | Olympus Corporation | Capsule type medical device system, and capsule type medical device |
| JP2005143560A (ja) * | 2003-11-11 | 2005-06-09 | Olympus Corp | カプセル型医療装置 |
| WO2005117951A1 (en) * | 2004-06-02 | 2005-12-15 | Technion Research & Development Foundation Ltd. | Methods and formulations for increasing intestinal function |
| WO2006077530A2 (en) * | 2005-01-18 | 2006-07-27 | Koninklijke Philips Electronics, N.V. | Electronically controlled ingestible capsule for sampling fluids in alimentary tract |
| WO2008030482A2 (en) | 2006-09-06 | 2008-03-13 | Innurvation Inc | System and method for acoustic information exchange involving an ingestible low power capsule |
| JP5074006B2 (ja) * | 2006-11-01 | 2012-11-14 | オリンパス株式会社 | カプセル型医療装置 |
| AU2008210291B2 (en) * | 2007-02-01 | 2013-10-03 | Otsuka Pharmaceutical Co., Ltd. | Ingestible event marker systems |
| US8235888B2 (en) * | 2008-07-08 | 2012-08-07 | Olympus Medical Systems Corp. | System for guiding capsule medical device |
| DE102009007513B4 (de) * | 2009-02-05 | 2011-02-10 | Siemens Aktiengesellschaft | Ablösen einer Endoskopiekapsel von einer Oberfläche einer Flüssigkeit |
| KR101432354B1 (ko) * | 2009-02-06 | 2014-08-20 | 더 프록터 앤드 갬블 캄파니 | 붕괴성 수분-함유 캡슐 |
| WO2011079050A2 (en) * | 2009-12-23 | 2011-06-30 | The Smart Pill Corporation | Method of evaluating constipation using an ingestible capsule |
| AU2010336330B2 (en) * | 2009-12-24 | 2016-04-28 | Rani Therapeutics, Llc | Swallowable drug delivery device and methods of drug delivery |
| WO2011112229A2 (en) * | 2010-03-10 | 2011-09-15 | Incube Labs, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| WO2011092995A1 (ja) * | 2010-01-29 | 2011-08-04 | オリンパスメディカルシステムズ株式会社 | カプセル型医療装置およびカプセル型医療装置の製造方法 |
| US8723640B2 (en) * | 2011-08-16 | 2014-05-13 | Elwha Llc | Distillation of status data relating to regimen compliance responsive to the presence and absence of wireless signals relating to one or more threshold frequencies |
| US9168000B2 (en) | 2013-03-13 | 2015-10-27 | Ethicon Endo-Surgery, Inc. | Meal detection devices and methods |
| IL250090B (en) * | 2017-01-12 | 2018-10-31 | Melcap Systems Ltd | A capsule is intended for ingestion by a subject and a system is intended for the digestive system |
-
2018
- 2018-06-12 AU AU2018282907A patent/AU2018282907B2/en active Active
- 2018-06-12 US US16/006,093 patent/US11103187B2/en not_active Expired - Fee Related
- 2018-06-12 EP EP18818502.9A patent/EP3638111A4/en not_active Withdrawn
- 2018-06-12 CN CN202310032767.1A patent/CN115844361A/zh active Pending
- 2018-06-12 CA CA3067021A patent/CA3067021A1/en active Pending
- 2018-06-12 CN CN201880052262.9A patent/CN110996754B/zh active Active
- 2018-06-12 JP JP2019568333A patent/JP7183194B2/ja active Active
- 2018-06-12 WO PCT/US2018/037153 patent/WO2018231865A2/en not_active Ceased
-
2021
- 2021-07-26 US US17/385,686 patent/US20220008013A1/en not_active Abandoned
-
2022
- 2022-11-22 JP JP2022186247A patent/JP2023010877A/ja active Pending
-
2024
- 2024-06-24 JP JP2024101550A patent/JP2024116415A/ja not_active Withdrawn
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006517827A (ja) | 2003-01-29 | 2006-08-03 | イー−ピル・ファーマ・リミテッド | 胃腸管内における活性薬物の送達 |
| US20080065168A1 (en) | 2005-12-05 | 2008-03-13 | Ophir Bitton | Ingestible Capsule For Appetite Regulation |
| US20090318783A1 (en) | 2008-06-18 | 2009-12-24 | Rohde Bemina L | System and method of evaluating a subject with an ingestible capsule |
| JP2015142754A (ja) | 2008-08-13 | 2015-08-06 | プロテウス デジタル ヘルス, インコーポレイテッド | 摂取可能デバイスおよびそれを生成する方法 |
| JP2012511961A (ja) | 2008-12-11 | 2012-05-31 | プロテウス バイオメディカル インコーポレイテッド | 携帯用内臓電気記録システムを用いた消化管機能の判断およびそれを用いた方法 |
| CN102088281A (zh) | 2009-12-04 | 2011-06-08 | 北京华清益康科技有限责任公司 | 一种基于消化道内体液酸碱度的电开关装置 |
| WO2011092936A1 (ja) | 2010-01-27 | 2011-08-04 | オリンパス株式会社 | 電源システム及び、その電源システムを搭載する医療用カプセル装置 |
| US20170000180A1 (en) | 2011-07-11 | 2017-01-05 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018231865A2 (en) | 2018-12-20 |
| CN110996754A (zh) | 2020-04-10 |
| US20220008013A1 (en) | 2022-01-13 |
| EP3638111A4 (en) | 2021-04-07 |
| AU2018282907A1 (en) | 2020-01-30 |
| US11103187B2 (en) | 2021-08-31 |
| CN115844361A (zh) | 2023-03-28 |
| JP2024116415A (ja) | 2024-08-27 |
| EP3638111A2 (en) | 2020-04-22 |
| AU2018282907B2 (en) | 2023-12-07 |
| US20180353133A1 (en) | 2018-12-13 |
| JP2020523123A (ja) | 2020-08-06 |
| CN110996754B (zh) | 2023-01-31 |
| WO2018231865A3 (en) | 2020-02-06 |
| JP2023010877A (ja) | 2023-01-20 |
| CA3067021A1 (en) | 2018-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7183194B2 (ja) | 胃内容排出パラメータを測定するための嚥下可能カプセル、システム、および方法 | |
| US10953224B2 (en) | Devices and methods for the treatment of metabolic disorders | |
| US7330753B2 (en) | Analysis of eating habits | |
| US9662240B2 (en) | Feedback systems and methods to enhance obstructive and other obesity treatments, optionally using multiple sensors | |
| JP5706504B2 (ja) | 摂取可能な事象マーカシステム | |
| JPH01284253A (ja) | 胃腸内筋電を利用した経腸給餌装置 | |
| JP2020523123A5 (enExample) | ||
| JP2012511961A (ja) | 携帯用内臓電気記録システムを用いた消化管機能の判断およびそれを用いた方法 | |
| US20240341690A1 (en) | Autoexpandable devices for obtaining impedance, pressure, and other measurements in the gastrointestinal tract and other organs | |
| AU2023371464A1 (en) | Method and system for assessing intra-abdominal health | |
| HK1064020B (en) | Analysis of eating habits |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210601 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210601 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20210902 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20210927 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210902 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20211007 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220330 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220405 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220630 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221025 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221122 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7183194 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |